Bard Associates’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.32M Sell
336,328
-13,295
-4% -$91.9K 0.75% 47
2025
Q1
$2.55M Buy
349,623
+97
+0% +$706 0.95% 37
2024
Q4
$2.8M Buy
349,526
+4,474
+1% +$35.9K 0.95% 34
2024
Q3
$2.53M Buy
345,052
+3,762
+1% +$27.6K 0.86% 42
2024
Q2
$2.24M Sell
341,290
-925
-0.3% -$6.06K 0.86% 42
2024
Q1
$3.23M Buy
342,215
+3,880
+1% +$36.6K 1.16% 24
2023
Q4
$2.66M Buy
338,335
+303,880
+882% +$2.39M 1.01% 33
2023
Q3
$232K Buy
34,455
+10,530
+44% +$70.9K 0.1% 150
2023
Q2
$234K Sell
23,925
-68
-0.3% -$665 0.09% 151
2023
Q1
$232K Buy
23,993
+1,000
+4% +$9.66K 0.1% 156
2022
Q4
$174K Buy
22,993
+2,000
+10% +$15.1K 0.07% 165
2022
Q3
$126K Buy
20,993
+100
+0.5% +$600 0.06% 165
2022
Q2
$112K Buy
20,893
+3,000
+17% +$16.1K 0.05% 170
2022
Q1
$89K Buy
17,893
+168
+0.9% +$836 0.03% 178
2021
Q4
$93K Hold
17,725
0.03% 174
2021
Q3
$98K Buy
17,725
+2,000
+13% +$11.1K 0.03% 168
2021
Q2
$112K Buy
+15,725
New +$112K 0.04% 167